Continuing Medical Education > Diabetes Conferences > Advanced Therapeutics Schedule

Global Advanced Therapeutics and Technologies
in Diabetes Care schedules

Conference information • Day one schedule • Day two schedule • Day three schedule • Overview • Objectives • Tuition • Return to Global Advanced Therapeutics home page

Day one

9 a.m. – International Diabetes Center and Evidence-based Medicine 
Roger Mazze, PhD
• Overview of International Diabetes Center
• Principles of Staged Diabetes Management
• Introduction to Advanced Technologies

10:30 – Coffee break

11:00 – Advanced Therapeutics: Incretin Hormones in Diabetes
Robert Cuddihy, MD
• Incretin physiology
• Incretin mimetics and potentiators
• Exenatide
• DPP-4 Inhibitors
• Clinical indications and criteria for patient selection
• Incorporating incretins into clinical pathways

12:30 p.m. – Lunch

1:15 – Introduction to Continuous Glucose Monitoring and Advanced  Technologies in Diabetes 
Sarah Borgman, RN, CDE; Ellie Strock, ANP-BC, CDE; Dawn Stoffels, CMA
• Demonstration of continuous glucose monitoring

1:45 – Small Group Presentations

• International Diabetes Center Tour
  Ellie Strock, ANP-BC, CDE
• Ambulatory Glucose Profile (AGP)
  David Wesley, BS
• Clinical Application of Continuous Glucose Monitoring for Decision-Making
  Roger Mazze, PhD

3:30 – Summary of day
• Calibrate CGM

4:00 – Adjourn

Day two

9 a.m. – Patient Education and Incretin-Based Therapies
Ellie Strock, ANP-BC, CDE; Maggie Powers, PhD, RD, LN, CDE
• Introduction of incretin hormones
• Pen instructions and skills evaluation
• Recognizing side effects
• Nutrition planning
• Glucose monitoring

10:30 – Coffee break

11:00 – Patient Discussion.
Discuss experiences with patients who are using incretin-based therapies
Roger Mazze, PhD; Ellie Strock, ANP-BC, CDE; Robert Cuddihy, MD;
Maggie Powers, PhD, RD, LN, CDE

12:30 p.m. – Lunch

1:30 – Clinical Decision-Making: Review of Case Studies.
Review clinical case studies of patients using incretin-based therapies
Roger Mazze, PhD; Ellie Strock, ANP-BC, CDE; Robert Cuddihy, MD; 
Maggie Powers, PhD, RD, LN, CDE
• Discussion

2:15 – Future Incretin-based Therapies
Robert Cuddihy, MD
• Exenatide LAR
• Liraglutide
• DPP-4 inhibitors
• New advances in diabetes care

3:00 – Controversies in Diabetes Care
Roger Mazze, PhD; Robert Cuddihy, MD
• Recent clinical trial findings (ACCORD, ADVANCE, RECORD, VADT) and recommendations
• Estimated Average Glucose vs. HbA1c
• HbA1c for diagnosis of diabetes

4:00 – Adjourn

Day three

9 a.m. – Approach to Health Care System Change to Improve Quality of Diabetes Care
• Organization
• Structure of care
• Data systems
• Incentives

10:00 – How Do Incretin-based Therapies Fit in Clinical Practice?
Roger Mazze, PhD and Robert Cuddihy, MD facilitating group discussion
• Indicators for use
• Glycemic effect
• Customize clinical pathway

11:00 – Coffee break

11:30 – Review Downloaded Participant CGM Data

Noon – Discussion
Roger Mazze, PhD; Robert Cuddihy, MD; David Wesley, BS
• Implementation planning
• Identify potential barriers and obstacles for use
• Develop strategies to overcome barriers and obstacles
• Demonstration of SDM International Web site 

12:30 p.m. – Presentation of Certificates

1:00 – Lunch

2:00 – Adjourn